J Lourtet-Hascoët1, A Bicart-See2, M P Félicé3, G Giordano4, E Bonnet2. 1. Microbiological Laboratory, Hôpital J. Ducuing, 15 rue Varsovie, 31300 Toulouse, France. Electronic address: julielourtet@hotmail.com. 2. Infectious Diseases Mobile Unit, J. Ducuing Hospital, Toulouse, France. 3. Microbiological Laboratory, Hôpital J. Ducuing, 15 rue Varsovie, 31300 Toulouse, France. 4. Traumatology and Orthopaedic Surgery Department, J. Ducuing Hospital, Toulouse, France.
Abstract
OBJECTIVES: The aim of this study was to assess the characteristics of periprosthetic joint infection (PJI) due to Staphylococcus lugdunensis and to compare these to the characteristics of PJI due to Staphylococcus aureus and Staphylococcus epidermidis. METHODS: A retrospective multicentre study including all consecutive cases of S. lugdunensis PJI (2000-2014) was performed. Eighty-eight cases of staphylococcal PJI were recorded: 28 due to S. lugdunensis, 30 to S. aureus, and 30 to S. epidermidis, as identified by Vitek 2 or API Staph (bioMérieux). RESULTS: Clinical symptoms were more often reported in the S. lugdunensis group, and the median delay between surgery and infection was shorter for the S. lugdunensis group than for the S. aureus and S. epidermidis groups. Regarding antibiotic susceptibility, the S. lugdunensis strains were susceptible to antibiotics and 61% of the patients could be treated with levofloxacin + rifampicin. The outcome of the PJI was favourable for 89% of patients with S. lugdunensis, 83% with S. aureus, and 97% with S. epidermidis. CONCLUSION: S. lugdunensis is an emerging pathogen with a pathogenicity quite similar to that of S. aureus. This coagulase-negative Staphylococcus must be identified precisely in PJI, in order to select the appropriate surgical treatment and antibiotics .
OBJECTIVES: The aim of this study was to assess the characteristics of periprosthetic joint infection (PJI) due to Staphylococcus lugdunensis and to compare these to the characteristics of PJI due to Staphylococcus aureus and Staphylococcus epidermidis. METHODS: A retrospective multicentre study including all consecutive cases of S. lugdunensis PJI (2000-2014) was performed. Eighty-eight cases of staphylococcal PJI were recorded: 28 due to S. lugdunensis, 30 to S. aureus, and 30 to S. epidermidis, as identified by Vitek 2 or API Staph (bioMérieux). RESULTS: Clinical symptoms were more often reported in the S. lugdunensis group, and the median delay between surgery and infection was shorter for the S. lugdunensis group than for the S. aureus and S. epidermidis groups. Regarding antibiotic susceptibility, the S. lugdunensis strains were susceptible to antibiotics and 61% of the patients could be treated with levofloxacin + rifampicin. The outcome of the PJI was favourable for 89% of patients with S. lugdunensis, 83% with S. aureus, and 97% with S. epidermidis. CONCLUSION:S. lugdunensis is an emerging pathogen with a pathogenicity quite similar to that of S. aureus. This coagulase-negative Staphylococcus must be identified precisely in PJI, in order to select the appropriate surgical treatment and antibiotics .
Authors: Ang Li; Nicholas Gow; Bridget L Atkins; Adrian Taylor; Tim Peto; Martin A McNally; Philippa C Matthews Journal: J Infect Date: 2017-05-25 Impact factor: 6.072
Authors: Stephan Josef Maria Steixner; Christopher Spiegel; Dietmar Dammerer; Alexander Wurm; Michael Nogler; Débora Cristina Coraça-Huber Journal: Antibiotics (Basel) Date: 2021-06-29
Authors: Luiza Pinheiro-Hubinger; Danilo Flávio Moraes Riboli; Lígia Maria Abraão; Eliane Patricia Lino Pereira Franchi; Maria de Lourdes Ribeiro de Souza da Cunha Journal: Pathogens Date: 2021-06-23
Authors: Elena De Vecchi; David A George; Carlo L Romanò; Fabrizio E Pregliasco; Roberto Mattina; Lorenzo Drago Journal: Infect Drug Resist Date: 2018-04-13 Impact factor: 4.003